FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$439M
This Quarter Return
+8.84%
1 Year Return
+25.58%
3 Year Return
+78.33%
5 Year Return
+134.68%
10 Year Return
+224.6%
AUM
$806M
AUM Growth
+$806M
(+5.1%)
Cap. Flow
-$36.2M
Cap. Flow
% of AUM
-4.49%
Top 10 Holdings %
Top 10 Hldgs %
34.27%
Holding
91
New
6
Increased
24
Reduced
39
Closed
2
Top Buys
| 1 |
Baxter International
BAX
|
$18M |
| 2 |
Conagra Brands
CAG
|
$11.1M |
| 3 |
Abercrombie & Fitch
ANF
|
$10.9M |
| 4 |
Teradata
TDC
|
$7.19M |
| 5 |
Stanley Black & Decker
SWK
|
$6.89M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$27.3M |
| 2 |
Oracle
ORCL
|
$10.4M |
| 3 |
Ryder
R
|
$9.93M |
| 4 |
Devon Energy
DVN
|
$9.63M |
| 5 |
Microsoft
MSFT
|
$8.71M |
Sector Composition
| 1 | Healthcare | 21.04% |
| 2 | Technology | 15.29% |
| 3 | Financials | 14.55% |
| 4 | Energy | 11.39% |
| 5 | Consumer Staples | 10.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Procter & Gamble
PG
$368B
| $860K | 0.11% | 10,563 | – | – |
|
77
Becton Dickinson
BDX
$55.3B
| $696K | 0.09% | 6,300 | – | – |
|
78
Novartis
NVS
$245B
| $693K | 0.09% | 8,619 | – | – |
|
79
AbbVie
ABBV
$372B
| $664K | 0.08% | 12,570 | – | – |
|
80
RTX Corp
RTX
$212B
| $590K | 0.07% | 5,185 | – | – |
|
81
IBM
IBM
$227B
| $586K | 0.07% | 3,126 | – | – |
|
82
iShares Core S&P 500 ETF
IVV
$662B
| $576K | 0.07% | 3,100 | – | – |
|
83
Abbott
ABT
$231B
| $482K | 0.06% | 12,570 | – | – |
|
84
US Bancorp
USB
$76B
| $386K | 0.05% | 9,553 | – | – |
|
85
Wells Fargo
WFC
$263B
| $337K | 0.04% | 7,421 | – | – |
|
|
ACET
86
DELISTED
Aceto Corp
ACET
| $296K | 0.04% | 11,851 | – | – |
|
87
JPMorgan Chase
JPM
$829B
| $261K | 0.03% | 4,471 | – | – |
|
88
Comerica
CMA
$9.07B
| $229K | 0.03% | +4,820 | New | +$229K |
|
89
Pfizer
PFE
$141B
| $214K | 0.03% | 6,993 | – | – |
|
90
Unilever
UL
$155B
| – | – | -92,482 | Closed | -$3.57M |
|
|
RFP
91
DELISTED
Resolute Forest Products Inc.
RFP
| – | – | -251,344 | Closed | -$3.45M |
|